title: Development of a commercial cigarette "market map" comparison methodology for evaluating new or non-conventional cigarettes.
abstract: A "market map" comparison methodology for cigarette smoke chemistry yields is presented. Federal Trade Commission machine-method smoke chemistry was determined for a range of filtered cigarettes from the US marketplace. These data were used to develop illustrative market maps for each smoke constituent as analytical tools for comparing new or non-conventional cigarettes to a sampling of the broader range of marketplace cigarettes. Each market map contained best-estimate "market-means," showing the relationship between commercial cigarette constituent and tar yields, and yield "market ranges" defined by prediction intervals. These market map means and ranges are the basis for comparing new cigarette smoke yields to those of conventional cigarettes. The potential utility of market maps for evaluating differences in smoke chemistry was demonstrated with 1R4F and 2R4F Kentucky reference cigarettes, an Accord cigarette, and an Advance cigarette. Conventional cigarette tobacco nicotine, nitrate, soluble ammonia, and tobacco specific nitrosamine levels are reported. Differences among conventional cigarette constituent yields at similar tar levels were explained in part by the chemical composition range of those cigarette tobaccos. The study also included a comparison of smoke constituent yields and in vitro smoke cytotoxicity and mutagenicity assay results for the 1R4F Kentucky reference cigarette and its replacement 2R4F. Significant smoke yield differences were noted for lead, NNK, and NNN. The majority of their smoke constituent yields were within the market range developed from the sampled conventional cigarettes. Within the sensitivity and specificity of the in vitro bioassays used, smoke toxic activity differences for the two reference cigarettes were not statistically significant. These results add to the limited information available for the 2R4F reference cigarette.
authors.affiliation: Philip Morris USA Research Center, PO Box 23234, Richmond, VA 23261, USA. MaryEllen.Counts@pmusa.com
authors.forename: M E
authors.initials: ME
authors.lastname: Counts
authors.forename: F S
authors.initials: FS
authors.lastname: Hsu
authors.forename: F J
authors.initials: FJ
authors.lastname: Tewes
mesh_terms: D000818:Animals; D002460:Cell Line; D004622:Embryo, Mammalian / Q000187:drug effects; D007854:Lead / Q000032:analysis; D040541:Marketing; D051379:Mice; D009152:Mutagenicity Tests; D009602:Nitrosamines / Q000032:analysis; D011237:Predictive Value of Tests; D012015:Reference Standards; D012016:Reference Values; D012044:Regression Analysis; D012906:Smoke / Q000009:adverse effects* / Q000032:analysis*; D013638:Tars / Q000737:chemistry / Q000592:standards; D018675:Toxicity Tests; D014481:United States
chemical_list: D009602:Nitrosamines; D012906:Smoke; D013638:Tars; C024746:tobacco tar; D007854:Lead; C016583:4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone; C008655:N'-nitrosonornicotine